CDSCO Enforces 30-Day Deadline for Drug Application Queries
CDSCO notice, dated May 4, 2026, stated that long-pending applications on the SUGAM portal awaiting query response will be rejected. It directs all applicants to respond to regulatory queries within 30 days of issuance. The notice highlights that numerous applications...
CDSCO MD5 Manufacturing License in 2026: Procedure & Documents
Central Drugs Standard Control Organization (CDSCO) is the apex regulatory body for all medical devices in India. The CDSCO MD5 license grants the permission to manufacture class A and B medical devices in India. Class A and B medical devices are low to moderate risk...
License to Conduct Clinical Performance Evaluation for New IVDs
Conducting clinical performance evaluation is critical to ensure the IVDs are accurate and reliable. Notably, IVD clinical performance evaluation is regulated in India. You have to mandatorily secure the MD 25 license to conduct clinical performance evaluation for new...